glp 1 and alzheimer's study Disappointing GLP-1 Results in Trial: Underscores Promise (and Limits) of Single-Agent Approaches Incretin and insulin signaling as

Shaun Noorian said: Personalized medicine isnt the future

10.3389/FMICB.2020.585428/TEXT 172 Rodrguez-DazaM

Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with type 2 diabetes

Recent data from LLY on Retatrutide (as well as other promising solutions presented at the American Diabetes Association conference) have made me consider something that seems inevitable on the surface, but the timeline of which may be greatly accelerated: obesity may have a cure (specifically - diabesity, the word for diabetes and obesity as comorbidities) in these new medications

GLP-1 helps regulate appetite, blood sugar, and digestion

For most people the real question is whether the patch itself creates meaningful weight loss, and the honest answer is that there is no strong clinical evidence that typical consumer patches deliver medication level effects through the skin